Chemotherapy Treats 2 With Lung Cancer Without Worsening IPF

Chemotherapy Treats 2 With Lung Cancer Without Worsening IPF

292860

Chemotherapy Treats 2 With Lung Cancer Without Worsening IPF

Two people with idiopathic pulmonary fibrosis (IPF) and poor lung function underwent chemotherapy for small cell lung cancer (SCLC) while continuing with their antifibrotic treatment, with clinical benefit evident in both. These findings suggest that “chemotherapy can be considered in patients with poor lung function due to the presence of both IPF and SCLC,” the scientists said. They also emphasized that antifibrotic therapies “cannot be discontinued” while IPF patients are undergoing cancer treatment, despite a…

You must be logged in to read/download the full post.